Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 381976, 10 pages
http://dx.doi.org/10.1155/2014/381976
Research Article

Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model

1Henan University of Traditional Chinese Medicine, Zhengzhou 450008, China
2College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, China
3Respiratory Disease Institute, The First Affiliated Hospital of Henan University of TCM, Zhengzhou 450000, China
4Bioinformatics Centre, School of Life Science, University of Electronic Science and Technology of China, Chengdu 610054, China

Received 17 January 2014; Revised 16 April 2014; Accepted 18 April 2014; Published 14 May 2014

Academic Editor: Syed Ibrahim Rizvi

Copyright © 2014 Jiansheng Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. F. Rabe, S. Hurd, A. Anzueto et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary,” The American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 6, pp. 532–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Pauwels, A. S. Buist, P. M. A. Calverley, C. R. Jenkins, and S. S. Hurd, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary,” Respiratory Care, vol. 46, no. 8, pp. 798–825, 2001. View at Google Scholar · View at Scopus
  3. J. B. Soriano and R. Rodríguez-Roisin, “Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation,” Proceedings of the American Thoracic Society, vol. 8, no. 4, pp. 363–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Wang, “Drug treatment and development of COPD,” Chinese Journal of Urban and Rural Industrial Hygiene, vol. 6, no. 3, pp. 22–23, 2006. View at Google Scholar
  5. P. B. Wu and J. G. Hu, “Application of β2 receptor agonists in the treatment of respiratory diseases,” Journal of Clinical Pulmonary Medicine, vol. 15, no. 6, pp. 993–994, 2010. View at Google Scholar
  6. K. Ito, S. Lim, G. Caramori et al., “A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8921–8926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. N. J. De Nijs, “Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options,” Minerva Medica, vol. 99, no. 1, pp. 23–43, 2008. View at Google Scholar · View at Scopus
  8. M. Z. Guo, Z. X. Yang, and Y. Q. Xiao, “Development of the study on the effects of Chinese herbs in treating COPD,” Chinese Medicine and Pharmacology, vol. 37, no. 5, p. 105, 2009. View at Google Scholar
  9. Q. Chen and S. M. Liu, “Study on the changes of blood rheology and the interfere effect of herbs with invigorating qi and promoting blood circulation effect in patients with chronic obstructive pulmonary disease,” Hunan Journal of Traditional Chinese Medicine, vol. 21, no. 3, pp. 3–7, 2005. View at Google Scholar
  10. C. Y. Tang, L. Lin, and Y. J. Xu, “Effects of strengthening earth to support metal on nutrition and lung function in stable COPD patients,” Journal of Nanjing University of Traditional Chinese Medicine, vol. 21, no. 3, article 16, 2005. View at Google Scholar
  11. L. Deng, Role of three regulating lung and kidney methods of inflammatory factor in lung tissue of rat with COPD and its remote effect [M.S. thesis], Henan University of Traditional Chinese Medicine, Zhengzhou, China, 2011.
  12. G. Xiong, S. Chen, W. Xie, X. D. Ye, and J. Lin, “Effects of Shenge Powder on lung function, the level of serum IL-8, TNF-α in stable COPD,” Chinese Journal of Geriatric Care, vol. 6, no. 4, pp. 37–39, 2008. View at Google Scholar
  13. S. Y. Li, J. S. Li, L. J. Ma, Q. W. Zhou, and C. H. Li, “Effects of Lung-tonifying and Kidney-strengthening Capsule on adhesion molecules in stable COPD patients,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 18, no. 1, article 500, 2003. View at Google Scholar
  14. H. L. Zhang, Efficacy of patients with stable chronic obstructive pulmonary disease by differentiation treatment and the influence of systemic inflammatory response with traditional Chinese medicine [M.S. thesis], Henan University of Traditional Chinese Medicine, Zhengzhou, China, 2010.
  15. L. S. Xu, “The influence of combined treatment of traditional Chinese medicine and western medicine on pulmonary function with the patients of moderate and severe COPD,” China and Foreign Medical Journal, vol. 5, no. 2, pp. 55–56, 2007. View at Google Scholar
  16. M. L. Hong, L. Y. Gao, and S. Z. Dai, “The efects of Yufeining on respiratory muscle strength and central respiratory drive in patients with COPD,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 11, no. 11, pp. 961–963, 2004. View at Google Scholar
  17. G. L. Jia, F. J. Tong, D. Z. Yu et al., “The clinical study of Yiqihuoxue combined ipratropium bromide inhalation in the treatment of chronic obstructive pulmonary disease,” Zhejiang Journal of Traditional Chinese Medicine, vol. 42, no. 9, pp. 510–511, 2007. View at Google Scholar
  18. S. Wang, H.-Y. Ji, N.-Z. Zhang et al., “Effect of yifei jianpi recipe on inflammatory cells, levels of interleukin-8 and tumor necrosis factor-alpha in sputum from patients with chronic obstructive pulmonary disease,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 25, no. 2, pp. 111–113, 2005. View at Google Scholar · View at Scopus
  19. S. Y. Li, J. S. Li, M. H. Wang et al., “Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study,” BMC Complementary and Alternative Medicine, vol. 12, no. 1, article 197, 2012. View at Google Scholar
  20. J.-S. Li, Y. Li, S.-Y. Li et al., “long-term effect of Tiaobu Feishen therapies on systemic and local inflammation response in rats with stable chronic obstructive pulmonary disease,” Zhong Xi Yi Jie He Xue Bao, vol. 10, no. 9, pp. 1039–1048, 2012. View at Google Scholar
  21. S. Y. Li, Y. Li, J. S. Li et al., “Efficacy and long-term effect of three therapies of invigorating lung and kidney for rat with stable COPD,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 27, no. 12, pp. 3116–3120, 2012. View at Google Scholar
  22. P. R. Chen, L. Cui, and J. F. Hou, “Advances in research on development of animal models of chronic obstructive pulmonary disease,” Acta Laboratorium Animalis Scientia Sinica, vol. 15, no. 5, pp. 238–242, 2007. View at Google Scholar
  23. S. Maere, K. Heymans, and M. Kuiper, “BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks,” Bioinformatics, vol. 21, no. 16, pp. 3448–3449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. T. Stuss, I. Peterkin, D. A. Guzman, C. Guzman, and A. K. Troyer, “Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures,” Journal of Clinical and Experimental Neuropsychology, vol. 19, no. 4, pp. 515–524, 1997. View at Google Scholar
  26. W. Q. Gan, S. F. P. Man, A. Senthilselvan, and D. D. Sin, “Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis,” Thorax, vol. 59, no. 7, pp. 574–580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen, “Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept,” The American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 12, pp. 1233–1240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. L. Wright, M. Cosio, and A. Churg, “Animal models of chronic obstructive pulmonary disease,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 295, no. 1, pp. L1–L15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Lee, D.-S. Lee, E.-K. Kim et al., “Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs,” The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 8, pp. 987–993, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. A. Zheng and S. H. He, “Progress in methods to produce COPD animal model,” Acta Laboratorium Animalis Scientia Sinica, vol. 11, no. 4, pp. 249–252, 2003. View at Google Scholar
  31. H. C. Kim, M. Mofarrahi, and S. N. A. Hussain, “Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease,” International Journal of COPD, vol. 3, no. 4, pp. 637–658, 2008. View at Google Scholar · View at Scopus
  32. M. J. Mador and E. Bozkanat, “Skeletal muscle dysfunction in chronic obstructive pulmonary disease,” Respiratory Research, vol. 2, no. 4, pp. 216–224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zuo, A. H. Hallman, M. K. Yousif, and M. T. Chien, “Oxidative stress, respiratory muscle dysfunction, and potential therapeutics in chronic obstructive pulmonary disease,” Frontiers in Biology, vol. 7, no. 6, pp. 506–513, 2012. View at Google Scholar
  34. A. G. D. M. Cavalcante and P. F. C. de Bruin, “The role of oxidative stress in COPD: current concepts and perspectives,” Jornal Brasileiro de Pneumologia, vol. 35, no. 12, pp. 1227–1237, 2009. View at Google Scholar · View at Scopus
  35. E. F. Wouters, “Local and systemic inflammation in chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 2, no. 1, pp. 26–33, 2005. View at Google Scholar
  36. S. Sethi, D. A. Mahler, P. Marcus, C. A. Owen, B. Yawn, and S. Rennard, “Inflammation in COPD: implications for management,” The The American Journal of Medicine, vol. 125, no. 12, pp. 1162–1170, 2012. View at Google Scholar
  37. R. O'Donnell, D. Breen, S. Wilson, and R. Djukanovic, “Inflammatory cells in the airways in COPD,” Thorax, vol. 61, no. 5, pp. 448–454, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Górska, M. Maskey-Warzechowska, and R. Krenke, “Airway inflammation in chronic obstructive pulmonary disease,” Current Opinion in Pulmonary Medicine, vol. 16, no. 2, pp. 89–96, 2010. View at Google Scholar
  39. J. A. Falk, O. A. Minai, and Z. Mosenifar, “Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 5, no. 4, pp. 506–512, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Gigante, A. M. Bennet, K. Leander, M. Vikström, and U. de Faire, “The interaction between coagulation factor 2 receptor and interleukin 6 haplotypes increases the risk of myocardial infarction in men,” PLoS ONE, vol. 5, no. 6, Article ID e11300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Gigante, M. Vikström, L. S. Meuzelaar et al., “Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels,” Thrombosis and Haemostasis, vol. 101, no. 5, pp. 943–953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. D. McDowall, M. S. Scott, and G. J. Barton, “PIPs: human protein-protein interaction prediction database,” Nucleic Acids Research, vol. 37, no. 1, pp. D651–D656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. Q. Li, C. Wang, Q. Zhang, C. Tang, N. Li, and J. Li, “The role of sphingosine kinase 1 in patients with severe acute pancreatitis,” Annals of Surgery, vol. 255, no. 5, pp. 954–962, 2012. View at Publisher · View at Google Scholar · View at Scopus